feed,title,long_url,short_url
ðŸ’°Barrons,Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.,https://barrons.com/articles/summit-therapeutics-cancer-biopharma-china-0a3bc966?mod=RTA,https://da.gd/TilSt
